Detalhe da pesquisa
1.
Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023.
Am J Transplant
; 2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499087
2.
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave.
Am J Transplant
; 23(1): 78-83, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148607
3.
Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
Clin Infect Dis
; 75(12): 2193-2200, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445690
4.
COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients.
Transplantation
; 108(5): 1249-1256, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291585
5.
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
Nat Commun
; 13(1): 4489, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927279
6.
Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients.
Lancet Infect Dis
; 23(8): e266-e267, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352879
7.
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab.
Lancet Infect Dis
; 23(5): 528-530, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030318